What is Driving the Rapid Growth of the Global Neurotechnology Market?
The global neurotechnology market is witnessing exceptional growth, fueled by increasing neurological disorders, technological innovation, and the growing adoption of neurostimulation and brain-computer interfaces (BCIs). Valued at USD 15.03 billion in 2024, the market is projected to expand at a CAGR of 11.90% from...
What is Driving Growth in the Binge Eating Disorder Market Globally?
The binge eating disorder (BED) market is witnessing notable expansion, fueled by rising awareness of mental health conditions, improved diagnostic capabilities, and the growing acceptance of psychological and pharmacological treatments. In 2024, the market was valued at USD 0.81 billion, and it is expected to reach USD 1.45...
How Is Artificial Intelligence Transforming Cancer Diagnostics Worldwide?
The global artificial intelligence in cancer diagnostics market, valued at USD 1.42 billion in 2024, is rapidly evolving as healthcare systems embrace AI-driven technologies for early, accurate, and personalized cancer detection. This transformative field is expected to grow at a CAGR of 22.40% from 2025 to 2034, reaching...
What is Driving the Growth of the Arrhythmia Monitoring Devices Market?
The global arrhythmia monitoring devices market was valued at USD 8.49 billion in 2024 and is projected to reach USD 16.86 billion by 2034, expanding at a CAGR of 7.10% during 2025–2034. This growth is largely driven by the rising prevalence of cardiovascular diseases, technological advancements in cardiac monitoring...
What is driving growth in the Acute Kidney Injury Treatment Market?
The global Acute Kidney Injury (AKI) Treatment Market was valued at USD 6.67 Billion in 2024 and is projected to reach approximately USD 14.00 Billion by 2034, growing at a CAGR of 7.70%.
The growth is primarily driven by:
Rising prevalence of chronic diseases such as diabetes, hypertension, and cardiovascular conditions....
What is the GLP-1 Agonists Drug Pipeline and Why is it Important?
The GLP-1 agonists drug pipeline analysis provides an in-depth look at one of the most dynamic areas of pharmaceutical research. GLP-1 (glucagon-like peptide-1) agonists are a class of drugs that mimic the natural GLP-1 hormone, which regulates blood sugar, insulin secretion, appetite, and gastric emptying. Originally developed...
Tiếng Việt 
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
